Scientists May Have Solved a Long-Standing Melanoma Treatment Mystery

With cancer treatment, when a drug is given may matter almost as much as which drug is used. For years, melanoma researchers have faced a frustrating contradiction. Experiments suggested that periodically stopping certain targeted drugs might help keep resistant cancer cells in check. Yet when intermittent dosing was tested in patients, continuous treatment performed better. [...]

from SciTechDaily https://ift.tt/ERiSrqb